Trial · NCT02210091
Adverse events22
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 22
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea | Gastrointestinal disorders | BAX 855 Safety Analysis Set | 5 | 66 | 5 |
| other | Diarrhoea | Gastrointestinal disorders | ADVATE Received Before BAX 855 | 0 | 31 | |
| other | Vomiting | Gastrointestinal disorders | BAX 855 Safety Analysis Set | 5 | 66 | 6 |
| other | Vomiting | Gastrointestinal disorders | ADVATE Received Before BAX 855 | 0 | 31 | |
| other | Pyrexia | General disorders | BAX 855 Safety Analysis Set | 13 | 66 | 20 |
| other | Pyrexia | General disorders | ADVATE Received Before BAX 855 | 0 | 31 | |
| other | Nasopharyngitis | Infections and infestations | BAX 855 Safety Analysis Set | 5 | 66 | 5 |
| other | Nasopharyngitis | Infections and infestations | ADVATE Received Before BAX 855 | 0 | 31 | |
| other | Upper Respiratory Tract Infection | Infections and infestations | BAX 855 Safety Analysis Set | 9 | 66 | 9 |
| other | Upper Respiratory Tract Infection | Infections and infestations | ADVATE Received Before BAX 855 | 0 | 31 | |
| other | Headache | Nervous system disorders | BAX 855 Safety Analysis Set | 5 | 66 | 7 |
| other | Headache | Nervous system disorders | ADVATE Received Before BAX 855 | 0 | 31 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | BAX 855 Safety Analysis Set | 4 | 66 | 8 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | ADVATE Received Before BAX 855 | 0 | 31 | |
| serious | Abdominal Pain | Gastrointestinal disorders | BAX 855 Safety Analysis Set | 1 | 66 | 1 |
| serious | Abdominal Pain | Gastrointestinal disorders | ADVATE Received Before BAX 855 | 0 | 31 | |
| serious | Gastritis | Gastrointestinal disorders | BAX 855 Safety Analysis Set | 1 | 66 | 1 |
| serious | Gastritis | Gastrointestinal disorders | ADVATE Received Before BAX 855 | 0 | 31 | |
| serious | Febrile Neutropenia | Blood and lymphatic system disorders | BAX 855 Safety Analysis Set | 1 | 66 | 1 |
| serious | Febrile Neutropenia | Blood and lymphatic system disorders | ADVATE Received Before BAX 855 | 0 | 31 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02210091/events